Strattera 60 mg and Generic Atomoxetine
Strattera is the brand name for atomoxetine, a prescription medicine. The Strattera brand remains represented by current U.S. labeling in 2026, and approved generic atomoxetine products are also available from other manufacturers.
Strattera vs Atomoxetine
Atomoxetine is the active ingredient. Strattera is Lilly’s brand product. Generic products use the atomoxetine name and may differ in manufacturer, capsule appearance, NDC and package size.
Current 60 mg Strattera Capsule
Current DailyMed labeling lists Strattera 60 mg as an oral capsule under NDC 0002-3239-30. The current package is labeled Rx only and identifies Lilly as the marketer.
The 60 mg strength is one member of a larger product family. This page confirms product identity and does not provide treatment or dose-selection advice.
Other Current Strengths
The June 2026 Strattera label lists 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg capsules. Approved generic atomoxetine manufacturers may offer corresponding strengths.
Prescription and Regulatory Status
Strattera is a human prescription drug marketed under an NDA. Generic atomoxetine products are separately approved under ANDAs.
In the United States, Strattera and atomoxetine capsules are prescription products, not over-the-counter medicines.
Availability and Price Context
Brand Strattera and generic atomoxetine can differ in cash price, formulary placement and copay. A useful comparison should specify the exact strength, capsule quantity and whether brand or generic is requested. This page does not state Paulsen’s Pharmacy stock or a guaranteed price.
Product Identification
- Brand name Strattera or generic atomoxetine.
- Strength: 60 mg or another prescribed strength.
- Dosage form: capsule.
- Manufacturer/labeler and NDC.
- Prescription and refill details.
Current U.S. labeling identifies Strattera as an ADHD medicine; it is not presented here as a weight-loss medicine. For broader help understanding generic names, brands and manufacturers, see Medication Information.
Reviewed by: Dr. Nancy Ann Curosh